Efficacy Study of Pentosan Polysulfate Sodium,Hydrodistension and Combination Therapy for Bladder Pain Syndrome
Launched by SAMSUNG MEDICAL CENTER · Jul 9, 2013
Trial Information
Current as of June 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. men and women who were over 18 years old and had symptoms over 6 months.
- • 2. 4 or more with an pain visual analogue score
- • 3. 12 or more O'Leary-Sant Intersttial Cystitis questionnaire (IC-Q) symptom and problem score and with a pain score and nocturia score of 2 or more.
- Exclusion Criteria:
- • 1. history of hydrodistention,augumentation cystoplasty due to IC/BPS
- • 2. pentosan polysulfate sodium (Elmiron) history over 1 month within 6 months.
- • 3. Women of child-bearing potential who were pregnant or nursing
- • 4. mean voided volume lesser than 40ml or over than 400ml.
- • 5. hematuria exceeds 1+ in the urinary dipstick (dipstick) examination.
- • 6. urinary tract infection during run-in periods.
- • 7. genitourinary tuberculosis or bladder,urethral and prostate cancer
- • 8. recurrent urinary tract infection
- • 9. history of hystrectomy,mid-urethral sling,pelvic organ prolapse repair,vaginal delivery or Cesarean section,prostate opreation or treatment etc within 6months.
- • 10. neurologic disease history of cerebral infaction,multiple sclerosis or parkinsonism etc.
About Samsung Medical Center
Samsung Medical Center (SMC) is a leading healthcare institution in South Korea, renowned for its commitment to advancing medical research and innovation. As a prominent clinical trial sponsor, SMC integrates cutting-edge technology and expert clinical practices to conduct rigorous studies aimed at improving patient outcomes. The center is dedicated to fostering collaborations with global research entities and adhering to the highest ethical standards, ensuring the integrity and reliability of its clinical trials. With a focus on diverse therapeutic areas, SMC plays a pivotal role in translating scientific discoveries into effective treatments, ultimately enhancing the quality of healthcare worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Trial Officials
Kyu-Sung Lee, MD,Ph.D
Principal Investigator
Samsung Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials